HealthCommentary

Exploring Human Potential

Iglehart and Thompson: Does the AMA Need “A Different Model of Advocacy”?

John Iglehart and Jeff Thompson MD The AMA’s vigorous opposition this week to the FDA’s consideration of mandating training for opioid prescribers to curb the current opioid epidemic (which the AMA’s liberal policies toward specialty designation and pharmaceutical underwriting helped create), called to mind the words in 2009 of Gundersen-Lutheran neonatologist and CEO, Jeff Thompson in […]

Show Buttons
Hide Buttons